Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Roundup: Children’s Motrin Trial Verdict, Gag’s Up For Roca Labs

This article was originally published in The Tan Sheet

Executive Summary

Jury finds J&J/McNeil not liable to warn on Children’s Motrin labels about a risk of severe skin conditions; gag’s up for Roca Labs; Omega Protein could be available; and more news in brief.

You may also be interested in...



FTC Pulls Curtain On Latest Initiative Against Bogus Weight Loss Claims

Agency based new website to help consumers identify false weight loss claims not on recent enforcement, but on previous investigations, including a 2011 complaint. "Those claims are lies," says official announcing website's launch.

Health, Beauty And Wellness News: Warnings, Launches, Funds, Fines

GMP, claim and branding problems in FDA's latest supplement sector warnings; FTC adding up Roca Labs' consumer redress; Thorne's hemp supplement sprouts again; SMPL earns passing grade from Zell Fund; Ocean Spray launches cranberry supplement; and ProMera reformulates full line.

NutraClick 'Free' Offer Curbed: Health And Wellness Industry News Roundup

Organic group updates global business guide; FTC doesn't split hairs on Coorga claim; social media etiquette lesson for UK nutritionals firm; and more news in brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107933

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel